Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3733 | 1844 | 48.9 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LENTIVIRAL VECTOR | Author keyword | 61 | 29% | 10% | 177 |
2 | LENTIVIRAL VECTORS | Author keyword | 57 | 39% | 6% | 114 |
3 | EXPT HEMATOL | Address | 17 | 10% | 8% | 152 |
4 | LENTIVIRUS | Author keyword | 16 | 11% | 7% | 134 |
5 | LENTIVIRAL TRANSGENESIS | Author keyword | 13 | 80% | 0% | 8 |
6 | CEA IMETI | Address | 12 | 86% | 0% | 6 |
7 | LYMPHAT CELL THER Y | Address | 12 | 86% | 0% | 6 |
8 | IMMUNODEFICIENCY | Address | 11 | 29% | 2% | 32 |
9 | U962 | Address | 11 | 69% | 0% | 9 |
10 | IIT UNIT MOL NEUROSCI | Address | 8 | 75% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LENTIVIRAL VECTOR | 61 | 29% | 10% | 177 | Search LENTIVIRAL+VECTOR | Search LENTIVIRAL+VECTOR |
2 | LENTIVIRAL VECTORS | 57 | 39% | 6% | 114 | Search LENTIVIRAL+VECTORS | Search LENTIVIRAL+VECTORS |
3 | LENTIVIRUS | 16 | 11% | 7% | 134 | Search LENTIVIRUS | Search LENTIVIRUS |
4 | LENTIVIRAL TRANSGENESIS | 13 | 80% | 0% | 8 | Search LENTIVIRAL+TRANSGENESIS | Search LENTIVIRAL+TRANSGENESIS |
5 | LAM PCR | 8 | 100% | 0% | 5 | Search LAM+PCR | Search LAM+PCR |
6 | HIV VECTOR | 6 | 71% | 0% | 5 | Search HIV+VECTOR | Search HIV+VECTOR |
7 | INSERTIONAL MUTAGENESIS | 6 | 13% | 2% | 42 | Search INSERTIONAL+MUTAGENESIS | Search INSERTIONAL+MUTAGENESIS |
8 | LENTIVIRUS VECTOR | 5 | 26% | 1% | 18 | Search LENTIVIRUS+VECTOR | Search LENTIVIRUS+VECTOR |
9 | MOKOLA | 4 | 67% | 0% | 4 | Search MOKOLA | Search MOKOLA |
10 | INTEGRASE DEFECTIVE | 4 | 75% | 0% | 3 | Search INTEGRASE+DEFECTIVE | Search INTEGRASE+DEFECTIVE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STABLE TRANSDUCTION | 67 | 51% | 5% | 93 |
2 | NONDIVIDING CELLS | 64 | 27% | 11% | 199 |
3 | SCID X1 | 53 | 56% | 4% | 65 |
4 | RETROVIRAL VECTORS | 51 | 17% | 15% | 278 |
5 | VECTOR INTEGRATION | 37 | 56% | 2% | 45 |
6 | CENTRAL DNA FLAP | 36 | 44% | 3% | 62 |
7 | LENTIVIRAL VECTOR | 33 | 19% | 9% | 160 |
8 | TRANSCRIPTION START REGIONS | 33 | 74% | 1% | 25 |
9 | CHS4 INSULATOR | 32 | 80% | 1% | 20 |
10 | VIVO GENE DELIVERY | 28 | 34% | 4% | 68 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN GENE THERAPY METHODS | 4 | 18% | 1% | 22 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Gene therapy clinical trials worldwide to 2012 an update | 2013 | 133 | 60 | 45% |
Lentiviral vectors: basic to translational | 2012 | 52 | 224 | 55% |
Ex vivo gene transfer and correction for cell-based therapies | 2011 | 109 | 156 | 40% |
Gene therapy for primary immunodeficiencies: part 1 | 2012 | 33 | 30 | 67% |
Retroviral Integrations in Gene Therapy Trials | 2012 | 39 | 83 | 58% |
Gene Therapy for Primary Immunodeficiencies | 2012 | 28 | 52 | 69% |
Gene therapy for PIDs: Progress, pitfalls and prospects | 2013 | 38 | 65 | 60% |
Recent Advances in Lentiviral Vector Development and Applications | 2010 | 95 | 163 | 58% |
Gene therapy for inherited immunodeficiency | 2014 | 10 | 77 | 53% |
Gene delivery by lentivirus vectors | 2007 | 132 | 194 | 57% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPT HEMATOL | 17 | 10% | 8.2% | 152 |
2 | CEA IMETI | 12 | 86% | 0.3% | 6 |
3 | LYMPHAT CELL THER Y | 12 | 86% | 0.3% | 6 |
4 | IMMUNODEFICIENCY | 11 | 29% | 1.7% | 32 |
5 | U962 | 11 | 69% | 0.5% | 9 |
6 | IIT UNIT MOL NEUROSCI | 8 | 75% | 0.3% | 6 |
7 | INVEST CLIN INTEGRE BIOTHER IES | 8 | 75% | 0.3% | 6 |
8 | PL VIROL GENE THER Y | 6 | 80% | 0.2% | 4 |
9 | MOL IMMUNOL UNIT | 6 | 10% | 3.1% | 57 |
10 | SAN RAFFAELE TELETHON GENE THER Y | 6 | 22% | 1.2% | 23 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000231170 | RETROVIRAL VECTORS//RETROVIRAL VECTOR//SELECTIVE AMPLIFIER GENE |
2 | 0.0000124290 | GENE THER Y S//PATHOTROPIC TARGETING//RETROVIRAL ENTRY |
3 | 0.0000116853 | 2A PEPTIDE//FMDV 2A//2A |
4 | 0.0000083916 | OMENN SYNDROME//SEVERE COMBINED IMMUNODEFICIENCY//T CELL LYMPHOPENIA |
5 | 0.0000072632 | FOAMY VIRUS//SPUMARETROVIRUS//ABT RETROVIRALE GENEXP S |
6 | 0.0000068994 | TET SYSTEM//PTRIDENT//TET ON SYSTEM |
7 | 0.0000067645 | HIV 1 INTEGRASE//INTEGRASE//RALTEGRAVIR |
8 | 0.0000065991 | CHIMERIC ANTIGEN RECEPTOR//ADOPTIVE CELL THERAPY//CHIMERIC IMMUNE RECEPTOR |
9 | 0.0000065547 | MARINER//SLEEPING BEAUTY//ARNOLD MABEL BECKMAN TRANSPOSON |
10 | 0.0000059992 | GENE MED GRP//GENEMED GRP//EXPT TREATMENT CYST FIBROSIS |